Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AMPKγ2 Regulates Cardiac Hypertrophy and Arrhythmias via Interacting With Myosin.

Circulation research·2026
Same author

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same author

Receptor-Guided AAV Tropism Engineering via MATCH.

ACS synthetic biology·2026
Same author

Flow-mediated endothelial remodeling and inflammation drive developmental vascular susceptibility in ldlr loss of function.

Nature communications·2026
Same author

Beyond Glycogen Storage: AMPKγ2 Regulates Cardiac Hypertrophy and Electrophysiology via Myosin Interaction.

bioRxiv : the preprint server for biology·2026
Same author

Evaluation of CRISPR/CasRx-Mediated VEGF mRNA Knockdown in Mouse Retina.

Methods in molecular biology (Clifton, N.J.)·2026

Related Experiment Video

Updated: Jul 8, 2026

Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
11:09

Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres

Published on: October 23, 2011

16.7K

Multiplexed Pan Soluble Ligandome Assaying via OASIS.

Yi-Hung Lee1, Yesh Doctor1, Yifan Zhang2

  • 1Department of Bioengineering, University of California San Diego, CA, USA.

Biorxiv : the Preprint Server for Biology
|January 7, 2026
PubMed
Summary

We developed Obligate Autocrine Signaling In Situ Screening (OASIS) to enable pooled screening of cell signaling ligands. This method anchors ligands to cells, enforcing autocrine signaling and accelerating ligandome discovery.

More Related Videos

Multiplexed Fluorescent Microarray for Human Salivary Protein Analysis Using Polymer Microspheres and Fiber-optic Bundles
08:50

Multiplexed Fluorescent Microarray for Human Salivary Protein Analysis Using Polymer Microspheres and Fiber-optic Bundles

Published on: October 10, 2013

12.1K
Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay
09:18

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay

Published on: October 20, 2018

7.9K

Related Experiment Videos

Last Updated: Jul 8, 2026

Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
11:09

Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres

Published on: October 23, 2011

16.7K
Multiplexed Fluorescent Microarray for Human Salivary Protein Analysis Using Polymer Microspheres and Fiber-optic Bundles
08:50

Multiplexed Fluorescent Microarray for Human Salivary Protein Analysis Using Polymer Microspheres and Fiber-optic Bundles

Published on: October 10, 2013

12.1K
Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay
09:18

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay

Published on: October 20, 2018

7.9K

Area of Science:

  • Cell biology
  • Molecular biology
  • Biotechnology

Background:

  • Screening soluble protein ligands is crucial for understanding cell signaling and drug discovery.
  • Current methods require arrayed formats due to non-cell-autonomous effects from ligand diffusion.
  • A need exists for multiplexed pooled assaying of ligands.

Purpose of the Study:

  • To develop a novel platform, Obligate Autocrine Signaling In Situ Screening (OASIS), for pooled screening of soluble protein ligands.
  • To enable exclusively autocrine signaling by anchoring ligands to the expressing cell surface.
  • To accelerate the functional interrogation of the human ligandome.

Main Methods:

  • Developed OASIS using lentiviral delivery of genetically barcoded ligands fused to a tethering domain.
  • Anchored proteins to the expressing cell's outer membrane to enforce autocrine signaling.
  • Validated OASIS with IFNA2 and EGF, and performed a pan-ligandome fitness screen in hiPSCs, followed by single-cell Perturb-Seq.

Main Results:

  • OASIS demonstrated uncompromised autocrine signaling with significantly reduced paracrine activity.
  • A pan-ligandome screen identified potent self-renewal factors, including FGF family ligands.
  • Single-cell Perturb-Seq mapped transcriptional remodeling induced by the ligandome library.

Conclusions:

  • OASIS is a platform enabling pooled assaying of soluble ligands by enforcing autocrine signaling.
  • The platform was validated by assaying all human ligands in hiPSCs, measuring fitness and transcriptional impacts.
  • OASIS facilitates rapid interrogation of ligands and engineered binders for cell signaling studies.